SOPH vs ALLO
Comparison between SOPHiA Genetics SA (SOPH, Company) and Allogene Therapeutics Inc (ALLO, Company).
Both SOPH and ALLO are from the Healthcare sector.
5-Year PerformanceSOPH has outperformed ALLO, delivering a return of -18.4% compared to -39.3%
SOPH vs ALLO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
SOPH vs ALLO - Historical Returns
Returns include dividend reinvestment.
SOPH vs ALLO - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | SOPH | ALLO |
|---|---|---|
| 2026 | +29.55% | +34.81% |
| 2025 | +46.39% | -37.73% |
| 2024 | -36.44% | -41.16% |
| 2023 | +109.33% | -44.27% |
| 2022 | -85.89% | -58.86% |
| 2021 | -15.87% | -42.15% |
| 2020 | N/A | -3.74% |
| 2019 | N/A | -5.73% |
| 2018 | N/A | +7.72% |
SOPH vs ALLO Drawdown Comparison
The maximum drawdown for SOPH was -91.35%, occurring on Nov 9, 2022. This drawdown has not yet recovered.
The maximum drawdown for ALLO was -98.24%, occurring on May 14, 2025. This drawdown has not yet recovered.
The current SOPH drawdown is -69.40%. The current ALLO drawdown is -96.63%.
| Rank | SOPH | ALLO |
|---|---|---|
| #1 | -91.35% Aug 31, 2021 - Nov 9, 2022 | -98.24% May 22, 2020 - May 14, 2025 |
| #2 | -10.71% Jul 26, 2021 - Aug 3, 2021 | -45.29% Nov 6, 2018 - May 11, 2020 |
| #3 | -7.38% Aug 6, 2021 - Aug 23, 2021 | -16.54% Oct 15, 2018 - Nov 2, 2018 |
| #4 | -2.69% Aug 23, 2021 - Aug 26, 2021 | -7.25% May 11, 2020 - May 14, 2020 |
| #5 | -2.06% Aug 3, 2021 - Aug 6, 2021 | -0.39% May 18, 2020 - May 20, 2020 |
| #6 | -0.94% Aug 26, 2021 - Aug 30, 2021 | N/A |
Correlation
Correlation between SOPH and ALLO is 0.78 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks